What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Virology, Leukemia, T cell, Cancer research and T-cell leukemia.
The Virology study combines topics in areas such as Immunology, Immune system, Transcription factor and Cell biology.
His biological study spans a wide range of topics, including Cytotoxic T cell and Ex vivo.
His T cell study combines topics in areas such as Cell growth, Asymptomatic, Asymptomatic carrier, CD5 and CD80.
His Cancer research research includes themes of Cell culture, Transfection, Carcinogenesis, Transforming growth factor and In vivo.
His T-cell leukemia research is multidisciplinary, relying on both Apoptosis, Peripheral blood mononuclear cell, Epigenetics and Molecular biology.
His most cited work include:
- Expression and function of OX40 ligand on human dendritic cells. (383 citations)
- Genetic and epigenetic inactivation of tax gene in adult T‐cell leukemia cells (262 citations)
- Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I–infected T-cell lines and primary adult T-cell leukemia cells (249 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Virology, Immunology, Leukemia, Cancer research and Molecular biology.
His Virology study incorporates themes from T cell, Cytotoxic T cell, Antibody and Antigen.
His work in Immunology addresses subjects such as Peripheral blood mononuclear cell, which are connected to disciplines such as Tumor necrosis factor alpha.
His research in Leukemia intersects with topics in Cell culture, Cell cycle, Virus and Lymphoma.
His research investigates the connection with Cancer research and areas like T-cell leukemia which intersect with concerns in Epigenetics.
The various areas that he examines in his Molecular biology study include Regulation of gene expression, Gene expression, Gene, Transfection and Receptor.
He most often published in these fields:
- Virology (41.20%)
- Immunology (33.91%)
- Leukemia (27.47%)
What were the highlights of his more recent work (between 2015-2021)?
- Virology (41.20%)
- Leukemia (27.47%)
- Human T-lymphotropic virus 1 (17.60%)
In recent papers he was focusing on the following fields of study:
Yuetsu Tanaka mostly deals with Virology, Leukemia, Human T-lymphotropic virus 1, Immunology and Cancer research.
Yuetsu Tanaka interconnects T cell, Monoclonal antibody and Antigen in the investigation of issues within Virology.
His study in Leukemia is interdisciplinary in nature, drawing from both Cell culture, Cell biology, Cell growth and Lymphoma.
His Human T-lymphotropic virus 1 research also works with subjects such as
- Molecular biology that intertwine with fields like Jurkat cells,
- Immunization which is related to area like In vitro and Neutralizing antibody.
The Cancer research study combines topics in areas such as Cytokine, Reprogramming, EZH2, T-cell leukemia and Epigenome.
The concepts of his Tropical spastic paraparesis study are interwoven with issues in Interferon, Peripheral blood mononuclear cell, Antibody and IL-2 receptor.
Between 2015 and 2021, his most popular works were:
- Polycomb-dependent epigenetic landscape in adult T-cell leukemia (67 citations)
- Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma. (35 citations)
- CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis (27 citations)
In his most recent research, the most cited papers focused on:
Yuetsu Tanaka mainly investigates Virology, Tropical spastic paraparesis, Immunology, Leukemia and Cancer research.
His Virology study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Molecular biology and T cell.
His studies deal with areas such as Peripheral blood mononuclear cell, Antibody, IL-2 receptor and Dendritic cell as well as Tropical spastic paraparesis.
His work on Immunology is being expanded to include thematically relevant topics such as Cell growth.
His Leukemia research integrates issues from Apoptosis, Growth inhibition, Kinase and P-TEFb.
His Cancer research research incorporates elements of Reprogramming, EZH2, Signal transduction, T-cell leukemia and Epigenome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
